Dewez Invest SPRL
Dewez Invest reported total assets of 419,029 € at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jan 2026).
The score of Dewez Invest shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -54 % Total assets +2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dewez Invest's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 23 Jan 2026
- Year ended 30 Jun 2024filed on 29 Nov 2024
- Year ended 30 Jun 2023filed on 19 Feb 2024
- Year ended 30 Jun 2022filed on 14 Nov 2022
- Year ended 30 Jun 2021filed on 01 Feb 2022
Dewez Invest's financial analysis
- Solvency21.5%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dewez Invest
Dewez Invest's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0535.770.293
- VAT number
- BE0535770293
- Peppol
- Registered · 0208:0535770293 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 18 Jun 2013
- Registered office
- 4600 Visé
- Latest accounts
- 2025 · filed on 23 Jan 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Dewez Invest (SPRL) has been based in Visé since 2013, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 22,135 € and equity of 90,153 €; its revenue is not published. Its solvency stands at 21.5%, below the median of its sector (40.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dewez Invest
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Vereenooghe SEW Retail sale of pharmaceutical products Ledegem · balance sheet 426,561 €
- Natexis Retail sale of pharmaceutical products Auderghem · balance sheet 404,337 €
- Yapharm Retail sale of pharmaceutical products Uccle · balance sheet 436,227 €
- Apotheek Oomen Retail sale of pharmaceutical products Antwerp · balance sheet 438,421 €
- Pharma Buyl-Louise Retail sale of pharmaceutical products Ixelles · balance sheet 380,658 €
- Goethals Retail sale of pharmaceutical products Kortrijk · balance sheet 475,802 €
- Van de Keere Retail sale of pharmaceutical products Zottegem · balance sheet 366,717 €
Frequently asked questions about Dewez Invest
What is the revenue of Dewez Invest?
Dewez Invest files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dewez Invest?
In Belgium, the VAT number is the company number prefixed with BE: BE0535770293 for Dewez Invest, if the company is VAT-registered. Its company number (CBE) is 0535.770.293.
Where is the registered office of Dewez Invest?
According to the CBE register, the registered office of Dewez Invest is in 4600 Visé.
What is the equity of Dewez Invest?
At the close of the 2025 financial year, the equity of Dewez Invest amounts to 90,153 €, a solvency of 21.5% of total assets.
Who manages Dewez Invest?
The register lists 1 active mandates at Dewez Invest. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dewez Invest
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →